Lexeo Therapeutics

LXEO · NASDAQ

$3.02+$0.26 (+9.42%)TodayMarket closed ·
Prev close $2.76

Who owns LXEO

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.1% of LXEO’s shares.

  • Montanova Capital, LLC8.1%
  • Affinity Asset Advisors LLC7.4%
  • BlackRock Institutional Trust Company, N.A.6.6%
  • RA Capital Management, LP6.4%
  • Next 6 largest institutions32.6%
  • All other shareholders38.9%
Top institutional holders of LXEO
HolderShares% of shares
Montanova Capital, LLC6.38M8.13%
Affinity Asset Advisors LLC5.81M7.40%
BlackRock Institutional Trust Company, N.A.5.21M6.63%
RA Capital Management, LP5.00M6.37%
Frazier Life Sciences Management, L.P.4.82M6.14%
State Street Investment Management (US)4.35M5.55%
Vestal Point Capital, LP4.32M5.50%
Paradigm BioCapital Advisors LP4.18M5.32%
Janus Henderson Investors3.95M5.04%
OrbiMed Advisors, LLC3.95M5.03%

Largest mutual fund holders

Top mutual fund holders of LXEO
HolderShares% of shares
State Street SPDR S&P Biotech ETF2.56M3.27%
Vanguard Total Stock Market Index Fund2.34M2.97%
iShares Russell 2000 ETF1.84M2.34%
JPMorgan Small Cap Growth Fund1.59M2.03%
Fidelity Small Cap Index Fund770.01K0.98%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $299.81K (7 trades) of LXEO on the open market, with no buys.

Latest LXEO insider transactions
InsiderTypeSharesValue
Bhalla Narinder PalAward54.75K—
Tamayo Louis EdwardAward54.75K—
Otero Jose ManuelAward54.75K—
Townsend Richard NolanAward145.50K—
Bhalla Narinder PalAward2.71K$9.71K
Otero Jose ManuelAward2.11K$5.58K
Townsend Richard NolanAward2.31K$6.10K
Tamayo Louis EdwardSale4.12K$20.20K
Otero Jose ManuelSale1.30K$6.46K
Townsend Richard NolanSale3.35K$16.56K

Short interest

Settled Sep 30, 2026

Shares short
19.25M
Days to cover
9.04
% of shares outstanding
24.51%
Average daily volume
2.13M
Change since last report
−6.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.